Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

This Ontario ER doctor's shifts ended in anger and tears. Here's what led her to quit and why she worries about the future

An Ontario emergency room physician has made the difficult decision to leave her position, citing systemic barriers that compromise patient...

Something Alarming Is About to Happen in Germany

The New York Times

Germany

September 4, 2026

James Orr and the gospel of the new British right

Financial Times

September 3, 2026

I’m Gen Z. I know why some of my peers are unemployable

The Times

September 3, 2026

Why my Gen Z mates don’t have boyfriends

The Times

September 6, 2026

Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil

Posted on September 8, 2026
By Business News Today
0 Views
1 min read

In brief

Generating AI summary…

Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil

Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the countrys PDP programme, providing access to around 70% of public-sector demand.